Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for H-share listing on the Hong Kong Stock Exchange and published the application materials.
Oulin Bio (688319.SH) announced that on November 25, 2025, the company applied to the Hong Kong Stock Exchange...
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) announced that on November 25, 2025, the company submitted an application to the Hong Kong Stock Exchange for an overseas public offering of shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. The application materials for this issuance and listing were also posted on the Hong Kong Stock Exchange website on the same day.
Related Articles
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
